Cancer researchers publish study on avidity enhancement of CAR T cells May 25, 2022 -- A team of cancer researchers led by Dr. Marcela Maus have published a preclinical study detailing the use of the Lumicks z-Movi Cell Avidity Analyzer to provide more nuanced development of cancer treatments. The study focused on using Lumicks’ technology to identify chimeric antigen receptor (CAR) T cells that are best suited to treat acute myeloid leukemia.Read More